Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
76.76
-0.05 (-0.07%)
At close: May 29, 2026, 4:00 PM EDT
76.61
-0.15 (-0.20%)
Pre-market: Jun 1, 2026, 5:16 AM EDT
Cytokinetics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Buy Initiates $99 | Buy | Initiates | $99 | +28.97% | May 18, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $103 → $76 | Buy | Maintains | $103 → $76 | -1.19% | May 18, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $92 → $97 | Buy | Reiterates | $92 → $97 | +26.37% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $140 | Buy | Reiterates | $140 | +82.39% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $95 → $105 | Buy | Maintains | $95 → $105 | +36.79% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $98 → $108 | Buy | Reiterates | $98 → $108 | +40.70% | May 7, 2026 |
Unknown Analyst Raymond James No rating | Raymond James | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $107 | Buy | Maintains | $107 | +39.40% | May 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.